The improved blood-brain barrier permeability of endomorphin-1 using the cell-penetrating peptide synB3 with three different linkages.

[1]  S. Sagan,et al.  Cell‐penetrating peptides: 20 years later, where do we stand? , 2013, FEBS letters.

[2]  Li-Li Zou,et al.  Send Orders of Reprints at Reprints@benthamscience.net Cell-penetrating Peptide-mediated Therapeutic Molecule Delivery into the Central Nervous System , 2022 .

[3]  Rui Wang,et al.  Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs , 2012, Medicinal research reviews.

[4]  郑俊海,et al.  International Journal of Nanomedicine , 2022 .

[5]  Xinguo Jiang,et al.  Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration. , 2011, Biomaterials.

[6]  E. Giralt,et al.  Shuttle-mediated drug delivery to the brain. , 2011, Angewandte Chemie.

[7]  Liang Feng,et al.  Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. , 2011, Biomaterials.

[8]  K. Kövér,et al.  Design, synthesis, pharmacological evaluation, and structure-activity study of novel endomorphin analogues with multiple structural modifications. , 2011, Journal of medicinal chemistry.

[9]  Thomas Knobloch,et al.  Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB) , 2011, Journal of drug targeting.

[10]  Shana O Kelley,et al.  Recent advances in the use of cell-penetrating peptides for medical and biological applications. , 2009, Advanced drug delivery reviews.

[11]  P. MacAry,et al.  Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides. , 2009, Organic & biomolecular chemistry.

[12]  H. Steinbusch,et al.  Delivery of peptide and protein drugs over the blood–brain barrier , 2009, Progress in Neurobiology.

[13]  André Pèlegrin,et al.  Cell-penetrating and cell-targeting peptides in drug delivery. , 2008, Biochimica et biophysica acta.

[14]  J. Scherrmann,et al.  CNS Delivery Via Adsorptive Transcytosis , 2008, The AAPS Journal.

[15]  Hong‐Mei Liu,et al.  Utilization of Combined Chemical Modifications to Enhance the Blood-Brain Barrier Permeability and Pharmacological Activity of Endomorphin-1 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  May C Morris,et al.  A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction. , 2006, Biochimica et biophysica acta.

[17]  Anna Moore,et al.  Crossing the blood–brain barrier: A potential application of myristoylated polyarginine for in vivo neuroimaging , 2005, NeuroImage.

[18]  A. Rees,et al.  Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy , 2005, Journal of Pharmacology and Experimental Therapeutics.

[19]  J. Temsamani,et al.  The use of Pep: Trans vectors for the delivery of drugs into the central nervous system , 2005 .

[20]  F. Bloom,et al.  Neuropeptides: opportunities for drug discovery , 2003, The Lancet Neurology.

[21]  G. Pasternak,et al.  Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[22]  F. Sharp,et al.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis , 2002, The Journal of Neuroscience.

[23]  C. Rousselle,et al.  Improved Brain Delivery of Benzylpenicillin with a Peptide-vector-mediated Strategy , 2002, Journal of drug targeting.

[24]  R. Egleton,et al.  Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability , 2001, Peptides.

[25]  K. Murayama,et al.  Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. , 2001, European journal of pharmacology.

[26]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[27]  Aimee M. Wilson,et al.  Dissociation of analgesic and rewarding effects of endomorphin-1 in rats , 2000, Peptides.

[28]  D. Lysle,et al.  Endomorphin-1 induces antinociception without immunomodulatory effects in the rat , 2000, Psychopharmacology.

[29]  D. Gozal,et al.  Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine. , 2000, American journal of respiratory and critical care medicine.

[30]  C. Rousselle,et al.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. , 2000, Molecular pharmacology.

[31]  N. Yanaihara,et al.  Synthesis and Receptor Binding of Cys-endomorphin , 1999 .

[32]  A. Kastin,et al.  A potent and selective endogenous agonist for the µ-opiate receptor , 1997, Nature.

[33]  Terry D. Lee,et al.  Determination of disulphide bridges in PG‐2, an antimicrobial peptide from porcine leukocytes , 1995, Journal of peptide science : an official publication of the European Peptide Society.

[34]  U. Bickel,et al.  In vivo cleavability of a disulfide-based chimeric opioid peptide in rat brain. , 1995, Bioconjugate chemistry.

[35]  N. Ede,et al.  Routine preparation of thiol oligonucleotides: application to the synthesis of oligonucleotide-peptide hybrids. , 1994, Bioconjugate chemistry.

[36]  T. Rudy,et al.  Sites of antinociceptive action of systemically injected morphine: involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone. , 1980, The Journal of pharmacology and experimental therapeutics.

[37]  J Carlsson,et al.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. , 1978, The Biochemical journal.

[38]  Li-Qun Gu,et al.  Single-molecule observation of the catalytic subunit of cAMP-dependent protein kinase binding to an inhibitor peptide. , 2005, Chemistry & biology.

[39]  T. Davis,et al.  A specific enzyme assay for aminopeptidase M in rat brain. , 1992, Life sciences.